These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22642124)

  • 1. [Immunomodulatory effects of vitamin D3 and bisphosphonates in nutritional osteoporosis in rats].
    Riasnyĭ VM; Apukhovs'ka LI; Velykyĭ MM; Shymans'kyĭ IO; Labudzyns'kyĭ DO; Komisarenko SV
    Ukr Biokhim Zh (1999); 2012; 84(2):73-80. PubMed ID: 22642124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vitamin D3 availability and functional activity of peripheral blood phagocytes in experimental type 1 diabetes].
    Labudzyns'kyĭ DO; Shymans'kyĭ IO; Riasnyĭ VM; Velykyĭ MM
    Ukr Biochem J; 2014; 86(2):107-18. PubMed ID: 24868917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activate vitamin D3 or bisphosphonate in glucocorticoid-induced osteoporosis].
    Imanishi Y; Nishizawa Y
    Clin Calcium; 2006 Nov; 16(11):1844-50. PubMed ID: 17079851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term effects on bone turnover markers of a single high dose of oral vitamin D₃.
    Rossini M; Gatti D; Viapiana O; Fracassi E; Idolazzi L; Zanoni S; Adami S
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E622-6. PubMed ID: 22298802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [How much calcium and vitamin D are really necessary].
    Brettschneider H
    MMW Fortschr Med; 2009 Apr; 151(16):18-9. PubMed ID: 19658290
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized trial of alendronate plus vitamin D3 versus standard care in osteoporotic postmenopausal women with vitamin D insufficiency.
    Ralston SH; Binkley N; Boonen S; Kiel DP; Reginster JY; Roux C; Chen L; Rosenberg E; Santora A;
    Calcif Tissue Int; 2011 Jun; 88(6):485-94. PubMed ID: 21479913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alendronate/vitamin D3 70 mg/2800 IU with and without additional 2800 IU vitamin D3 for osteoporosis: results from the 24-week extension of a 15-week randomized, controlled trial.
    Binkley N; Ringe JD; Reed JI; Ljunggren O; Holick MF; Minne HW; Liu M; Lamotta A; West JA; Santora AC
    Bone; 2009 Apr; 44(4):639-47. PubMed ID: 19185560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Frontiers in vitamin D; basic Research and clinical application. Effect of active vitamin D3 on osteoporosis].
    Yamauchi M; Sugimoto T
    Clin Calcium; 2011 Nov; 21(11):17-24. PubMed ID: 22040817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined therapies in osteoporosis: bisphosphonates and vitamin D-hormone analogs.
    Schacht E; Dukas L; Richy F
    J Musculoskelet Neuronal Interact; 2007; 7(2):174-84. PubMed ID: 17627088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficiency of calcium and vitamin D3 in the treatment of steroid osteoporosis in patients with hormone dependent bronchial asthma].
    Ememl'ianov AV; Shevelev SE; Murzin BA; Amosov VI
    Ter Arkh; 1999; 71(11):68-9. PubMed ID: 10626343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis.
    Deane A; Constancio L; Fogelman I; Hampson G
    BMC Musculoskelet Disord; 2007 Jan; 8():3. PubMed ID: 17214897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug therapy of secondary osteoporosis: glucocorticoid-induced osteoporosis].
    Soen S
    Nihon Rinsho; 2009 May; 67(5):985-90. PubMed ID: 19432121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination therapy for osteoporosis].
    Hagino H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():316-20. PubMed ID: 18161124
    [No Abstract]   [Full Text] [Related]  

  • 14. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
    Reginster JY; Lecart MP; Richy F
    J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current Topics on Vitamin D. Combined therapy of anti-resorptive drug and active vitamin D].
    Endo I
    Clin Calcium; 2015 Mar; 25(3):433-8. PubMed ID: 25716817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The successful development of bisphosphonates in the therapy of osteoporosis].
    Fassbender WJ; Stumpf UC; Kurth A
    Med Klin (Munich); 2006 Jun; 101 Suppl 1():6-14. PubMed ID: 16826363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and treatment of glucocorticoid-induced osteoporosis in collagen vascular disease].
    Kawano S; Kumagai S
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():504-7. PubMed ID: 18161157
    [No Abstract]   [Full Text] [Related]  

  • 18. [Unsuccessful vitamin D treatment].
    Schmedes A; Hey H; Larsson I; Christensen MJ; Brandslund I
    Ugeskr Laeger; 2012 Feb; 174(9):566-9. PubMed ID: 22369905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticosteroids: no drug prevention of fractures needed.
    Prescrire Int; 2009 Aug; 18(102):175. PubMed ID: 19746563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a novel transdermal patch of alendronate, a nitrogen-containing bisphosphonate, for the treatment of osteoporosis.
    Kusamori K; Katsumi H; Abe M; Ueda A; Sakai R; Hayashi R; Hirai Y; Quan YS; Kamiyama F; Sakane T; Yamamoto A
    J Bone Miner Res; 2010 Dec; 25(12):2582-91. PubMed ID: 20533374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.